세계의 단백질 시퀀싱 시장 규모, 점유율, 동향 분석 리포트 : 제품 및 서비스별(단백질 시퀀싱 제품, 단백질 시퀀스 서비스), 용도별, 최종사용자별, 부문별 예측(2022-2030년)

Protein Sequencing Market Growth & Trends:

The global protein sequencing market size is expected to reach USD 1.77 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 3.5% from 2022 to 2030. The increasing research in genomics and proteomics, coupled with the rising demand for protein-based therapeutics around the world, is contributing to the demand for protein sequencing. For instance, in May 2022, Amphista Therapeutics announced a collaboration with Bristol Myers Squibb for discovering and developing small-molecule protein degraders. Bristol Myers Squibb is expected to receive an exclusive license to manufacture and commercialize the product. Hence, the rising demand for protein degradation is anticipated to extend the application scope for protein sequencing.

Increasing funding and grants for biomedical R&D by governments and major companies are anticipated to have a significant impact on the usage of sequencing. As per a WHO report published in January 2022, in 2019, approximately 80,178 grants were awarded to biomedical research from 11 funders. Out of those, 69.4% of grants were assigned for research, while 19.5% were for training purposes. Moreover, approximately 75% of the overall grants were awarded to organizations in the U.S. Federal funding in the U.S. has created the demand for protein sequencing from end-users.

Similarly, the usage of recombinant antibodies is growing in the management of rheumatoid arthritis, cancer, and other pathological conditions, which is likely to increase the use of protein sequencing. According to research published in February 2022, the de novo antibody sequencing through mass spectrometry techniques is feasible for numerous complicated clinical samples via endogenous sources including serum. Hence, such research is likely to increase applications of the market in the area of therapeutics.

The COVID-19 pandemic resulted in increased usage of protein sequencing in assessing the components of the COVID-19 virus, along with assessing the changes in the genome post-COVID-19. A study published in September 2022 performed 97,437 COVID-19 protein sequencing to detect non-synonymous mutations in 26 various sequences. This had a positive impact on the global market.

The growing demand for personalized medicine and vaccination is likely to be an essential factor for the market growth since it is an emerging application of the market. For instance, in January 2022, Amgen collaborated with Generate Biomedicines in order to discover and advance protein-based therapeutics for multiple fields. The collaboration is estimated to be valued at around USD 1.9 billion.

On the other hand, advancements in sampling technologies covering proteomes are expected to support the growth of the technique in the proteome market. However, the regulation on intellectual property such as patents on protein sequencing is not formally drafted. For instance, in Australia, a patent on sequencing highly depends on the jurisdiction. The lack of patenting regulations restrains academic institutions to conduct R&D on developing new technologies.

Protein Sequencing Market Report Highlights:

• By product and service, the service segment is projected to register the fastest growth rate during the forecast period. This can be credited to the increased funding and grants to academic institutions, such as the University of California and Yale University, to support their research in the biomedical application of the sequencing

• By application, the bio-therapeutics segment held the largest share in 2021 and is anticipated to witness the fastest growth during the forecast period. This can be attributed to the increase in R&D investment for developing protein-based therapeutics and strategic initiatives such as fundraising

• By end-user, the academic institutes and research centers segment held the largest share in 2021. This is owing to the presence of well-equipped facilities for research in developed countries

• North America led the market in 2021 with a revenue share of over 35.0%. This is attributed to the increasing accessibility of funding opportunities for start-ups and academic institutions, along with the existence of key players in the region

Table of Contents

Chapter 1 Research Methodology

• 1.1 Country Wise Market: Base Estimates
• 1.2 Global Market: CAGR Calculation
• 1.3 Region-Based Segment Share Calculation
• 1.4 Research Scope & Assumptions
• 1.5 List of Data Sources
  • 1.5.1 Data for primary interviews, by sources
  • 1.5.2 Data for primary interviews, by region

Chapter 2 Executive Summary

• 2.1 Market Snapshot

Chapter 3 Protein Sequencing Market Variables, Trends & Scope

• 3.1 Market Segmentation & Scope
• 3.2 Market Driver Analysis
  • 3.2.1 The development of commercial and non-commercial antibody research
  • 3.2.2 Increasing biomedical research to develop biomarkers
  • 3.2.3 Rising funding by government for proteomics and genomics research
• 3.3 Market Restraint Analysis
  • 3.3.1 High maintenance of equipment
• 3.4 Protein Sequencing - SWOT Analysis, By Factor (political & legal, economic and technological)
• 3.5 Industry Analysis - Porter's
• 3.6 Protein Sequencing Market: Market Position Analysis, 2021
• 3.7 COVID-19 Impact Analysis

Chapter 4 Protein Sequencing Market: Product and Service Estimates & Trend Analysis

• 4.1 Protein Sequencing Market: Product and Service Movement Analysis
• 4.2 Protein Sequencing Products
  • 4.2.1 Protein Sequencing Productsmarket, 2018 - 2030 (USD Million)
    • 4.2.1.1 Reagents & Consumables market, 2018 -2030 (USD Million)
    • 4.2.1.2 Instruments market, 2018 -2030 (USD Million)
    • 4.2.1.2.1 Mass Spectrometry Instruments market, 2018 -2030 (USD Million)
    • 4.2.1.2.2 Edman Degradation Sequencers market, 2018 -2030 (USD Million)
    • 4.2.1.3 Software market, 2018 -2030 (USD Million)
• 4.3 Protein Sequencing Services
  • 4.3.1 Protein Sequencing Servicesmarket, 2018 - 2030 (USD Million)

Chapter 5 Protein Sequencing Market: Application Estimates & Trend Analysis

• 5.1 Protein Sequencing Market: Application Movement Analysis
• 5.2 Bio-therapeutics
  • 5.2.1 Bio-therapeutics market, 2018 - 2030 (USD Million)
• 5.3 Genetic Engineering
  • 5.3.1 Genetic Engineering market, 2018 - 2030 (USD Million)
• 5.4 Others
  • 5.4.1 Others market, 2018 - 2030 (USD Million)

Chapter 6 Protein Sequencing Market: End-user Estimates & Trend Analysis

• 6.1 Protein Sequencing Market: End-user Movement Analysis
• 6.2 Academic Institutes & Research Centers
  • 6.2.1 Academic Institutes & Research Centersmarket, 2018 - 2030 (USD Million)
• 6.3 Pharmaceutical & Biotechnology Companies
  • 6.3.1 Pharmaceutical & Biotechnology Companies market, 2018 - 2030 (USD Million)
• 6.4 Others
  • 6.4.1 Others Market, 2018 - 2030 (USD Million)

Chapter 7 Protein Sequencing Market: Regional Estimates & Trend Analysis, Product and Service, Application, End-user

• 7.1 Protein Sequencing Market Share By Region, 2021 & 2030
• 7.2 North America
  • 7.2.1 North America Protein Sequencing market, by product and service, 2018 - 2030 (USD Million)
  • 7.2.2 North America Protein Sequencing market, by application, 2018 - 2030 (USD Million)
  • 7.2.3 North America Protein Sequencing market, by end-user, 2018 - 2030 (USD Million)
  • 7.2.4 U.S.
    • 7.2.4.1 U.S. Protein Sequencing market, by product and service, 2018 - 2030 (USD Million)
    • 7.2.4.2 U.S. Protein Sequencing market, by application, 2018 - 2030 (USD Million)
    • 7.2.4.3 U.S. Protein Sequencing market, by end-user, 2018 - 2030 (USD Million)
  • 7.2.5 Canada
    • 7.2.5.1 Canada Protein Sequencing market, by product and service, 2018 - 2030 (USD Million)
    • 7.2.5.2 Canada Protein Sequencing market, by application, 2018 - 2030 (USD Million)
    • 7.2.5.3 Canada Protein Sequencing market, by end-user, 2018 - 2030 (USD Million)
• 7.3 Europe
  • 7.3.1 Europe Protein Sequencing market, by product and service, 2018 - 2030 (USD Million)
  • 7.3.2 Europe Protein Sequencing market, by application, 2018 - 2030 (USD Million)
  • 7.3.3 Europe Protein Sequencing market, by end-user, 2018 - 2030 (USD Million)
  • 7.3.4 Germany
    • 7.3.4.1 Germany Protein Sequencing market, by product and service, 2018 - 2030 (USD Million)
    • 7.3.4.2 Germany Protein Sequencing market, by application, 2018 - 2030 (USD Million)
    • 7.3.4.3 Germany Protein Sequencing market, by end-user,2018 - 2030 (USD Million)
  • 7.3.5 U.K.
    • 7.3.5.1 U.K. Protein Sequencing market, by product and service, 2018 - 2030 (USD Million)
    • 7.3.5.2 U.K. Protein Sequencing market, by application, 2018 - 2030 (USD Million)
    • 7.3.5.3 U.K. Protein Sequencing market, by end-user, 2018 - 2030 (USD Million)
  • 7.3.6 France
    • 7.3.6.1 France Protein Sequencing market, by product and service, 2018 - 2030 (USD Million)
    • 7.3.6.2 France Protein Sequencing market, by application, 2018 - 2030 (USD Million)
    • 7.3.6.3 France Protein Sequencing market, by end-user, 2018 - 2030 (USD Million)
  • 7.3.7 Italy
    • 7.3.7.1 ItalyProtein Sequencing market, by product and service, 2018 - 2030 (USD Million)
    • 7.3.7.2 ItalyProtein Sequencing market, by application, 2018 - 2030 (USD Million)
    • 7.3.7.3 ItalyProtein Sequencing market, by end-user, 2018 - 2030 (USD Million)
  • 7.3.8 Spain
    • 7.3.8.1 SpainProtein Sequencing market, by product and service, 2018 - 2030 (USD Million)
    • 7.3.8.2 SpainProtein Sequencing market, by application, 2018 - 2030 (USD Million)
    • 7.3.8.3 SpainProtein Sequencing market, by end-user, 2018 - 2030 (USD Million)
• 7.4 Asia Pacific
  • 7.4.1 Asia Pacific Protein Sequencing market, by product and service, 2018 - 2030 (USD Million)
  • 7.4.2 Asia Pacific Protein Sequencing market, by application, 2018 - 2030 (USD Million)
  • 7.4.3 Asia Pacific Protein Sequencing market, by end-user, 2018 - 2030 (USD Million)
  • 7.4.4 Japan
    • 7.4.4.1 Japan Protein Sequencing market, by product and service, 2018 - 2030 (USD Million)
    • 7.4.4.2 Japan Protein Sequencing market, by application, 2018 - 2030 (USD Million)
    • 7.4.4.3 Japan Protein Sequencing market, by end-user, 2018 - 2030 (USD Million)
  • 7.4.5 China
    • 7.4.5.1 China Protein Sequencing market, by product and service, 2018 - 2030 (USD Million)
    • 7.4.5.2 China Protein Sequencing market, by application, 2018 - 2030 (USD Million)
    • 7.4.5.3 China Protein Sequencing market, by end-user, 2018 - 2030 (USD Million)
  • 7.4.6 India
    • 7.4.6.1 India Protein Sequencing market, by product and service, 2018 - 2030 (USD Million)
    • 7.4.6.2 India Protein Sequencing market, by application, 2018 - 2030 (USD Million)
    • 7.4.6.3 India Protein Sequencing market, by end-user, 2018 - 2030 (USD Million)
  • 7.4.7 South Korea
    • 7.4.7.1 South Korea Protein Sequencing market, by product and service, 2018 - 2030 (USD Million)
    • 7.4.7.2 South Korea Protein Sequencing market, by application, 2018 - 2030 (USD Million)
    • 7.4.7.3 South Korea Protein Sequencing market, by end-user, 2018 - 2030 (USD Million)
  • 7.4.8 Australia
    • 7.4.8.1 Australia Protein Sequencing market, by product and service, 2018 - 2030 (USD Million)
    • 7.4.8.2 Australia Protein Sequencing market, by application, 2018 - 2030 (USD Million)
    • 7.4.8.3 Australia Protein Sequencing market, by end-user, 2018 - 2030 (USD Million)
• 7.5 Latin America
  • 7.5.1 Latin America Protein Sequencing market, by product and service, 2018 - 2030 (USD Million)
  • 7.5.2 Latin America Protein Sequencing market, by application, 2018 - 2030 (USD Million)
  • 7.5.3 Latin America Protein Sequencing market, by end-user, 2018 - 2030 (USD Million)
  • 7.5.4 Brazil
    • 7.5.4.1 Brazil Protein Sequencing market, by product and service, 2018 - 2030 (USD Million)
    • 7.5.4.2 Brazil Protein Sequencing market, by application, 2018 - 2030 (USD Million)
    • 7.5.4.3 Brazil Protein Sequencing market, by end-user, 2018 - 2030 (USD Million)
  • 7.5.5 Mexico
    • 7.5.5.1 Mexico Protein Sequencing market, by product and service, 2018 - 2030 (USD Million)
    • 7.5.5.2 Mexico Protein Sequencing market, by application, 2018 - 2030 (USD Million)
    • 7.5.5.3 Mexico Protein Sequencing market, by end-user, 2018 - 2030 (USD Million)
  • 7.5.6 Argentina
    • 7.5.6.1 Argentina Protein Sequencing market, by product and service, 2018 - 2030 (USD Million)
    • 7.5.6.2 Argentina Protein Sequencing market, by application, 2018 - 2030 (USD Million)
    • 7.5.6.3 Argentina Protein Sequencing market, by end-user, 2018 - 2030 (USD Million)
• 7.6 MEA
  • 7.6.1 MEA Protein Sequencing market, by product and service, 2018 - 2030 (USD Million)
  • 7.6.2 MEA Protein Sequencing market, by application, 2018 - 2030 (USD Million)
  • 7.6.3 MEA Protein Sequencing market, by end-user, 2018 - 2030 (USD Million)
  • 7.6.4 South Africa
    • 7.6.4.1 South Africa Protein Sequencing market, by product and service, 2018 - 2030 (USD Million)
    • 7.6.4.2 South Africa Protein Sequencing market, by application, 2018 - 2030 (USD Million)
    • 7.6.4.3 South Africa Protein Sequencing market, by end-user, 2018 - 2030 (USD Million)
  • 7.6.5 Saudi Arabia
    • 7.6.5.1 Saudi Arabia Protein Sequencing market, by product and service, 2018 - 2030 (USD Million)
    • 7.6.5.2 Saudi Arabia Protein Sequencing market, by application, 2018 - 2030 (USD Million)
    • 7.6.5.3 Saudi Arabia Protein Sequencing market, by end-user, 2018 - 2030 (USD Million)
  • 7.6.6 UAE
    • 7.6.6.1 UAE Protein Sequencing market, by product and service, 2018 - 2030 (USD Million)
    • 7.6.6.2 UAE Protein Sequencing market, by application, 2018 - 2030 (USD Million)
    • 7.6.6.3 UAE Protein Sequencing market, by end-user, 2018 - 2030 (USD Million)

Chapter 8 Competitive Landscape

• 8.1 Strategy Framework
• 8.2 Company Profiles
  • 8.2.1 Thermo Fisher Scientific, Inc.
    • 8.2.1.1 Company Overview
    • 8.2.1.2 Financial Performance
    • 8.2.1.3 Product Benchmarking
    • 8.2.1.4 Strategic Initiatives
  • 8.2.2 Shimadzu Corporation
    • 8.2.2.1 Company Overview
    • 8.2.2.2 Financial Performance
    • 8.2.2.3 Product Benchmarking
    • 8.2.2.4 Strategic Initiatives
  • 8.2.3 Agilent Technologies, Inc.
    • 8.2.3.1 Company Overview
    • 8.2.3.2 Financial Performance
    • 8.2.3.3 Product Benchmarking
    • 8.2.3.4 Strategic Initiatives
  • 8.2.4 Rapid Novor, Inc.
    • 8.2.4.1 Company Overview
    • 8.2.4.2 Financial Performance
    • 8.2.4.3 Product Benchmarking
    • 8.2.4.4 Strategic Initiatives
  • 8.2.5 Charles River Laboratories
    • 8.2.5.1 Company Overview
    • 8.2.5.2 Financial Performance
    • 8.2.5.3 Product Benchmarking
    • 8.2.5.4 Strategic Initiatives
  • 8.2.6 Proteome Factory AG
    • 8.2.6.1 Company Overview
    • 8.2.6.2 Financial Performance
    • 8.2.6.3 Product Benchmarking
    • 8.2.6.4 Strategic Initiatives
  • 8.2.7 Selvita
    • 8.2.7.1 Company Overview
    • 8.2.7.2 Financial Performance
    • 8.2.7.3 Product Benchmarking
    • 8.2.7.4 Strategic Initiatives
  • 8.2.8 Bioinformatics Solutions Inc.
    • 8.2.8.1 Company Overview
    • 8.2.8.2 Financial Performance
    • 8.2.8.3 Product Benchmarking
    • 8.2.8.4 Strategic Initiatives
  • 8.2.9 Creative Proteomics
    • 8.2.9.1 Company Overview
    • 8.2.9.2 Financial Performance
    • 8.2.9.3 Product Benchmarking
    • 8.2.9.4 Strategic Initiatives
  • 8.2.10 Alphalyse
    • 8.2.10.1 Company Overview
    • 8.2.10.2 Financial Performance
    • 8.2.10.3 Product Benchmarking
    • 8.2.10.4 Strategic Initiatives
    • 8.2.11Bruker
    • 8.2.11.1 Company Overview
    • 8.2.11.2 Financial Performance
    • 8.2.11.3 Product Benchmarking
    • 8.2.11.4 Strategic Initiatives